Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art

Cancer and COVID-19 are both well-established risk factors predisposing to thrombosis. Both disease entities are correlated with increased incidence of venous thrombotic events through multifaceted pathogenic mechanisms involving the interaction of cancer cells or SARS-CoV2 on the one hand and the c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2022-07, Vol.42 (7), p.3261-3274
Hauptverfasser:	DIMAKAKOS, EVANGELOS, GOMATOU, GEORGIA, CATALANO, MARIELLA, OLINIC, DAN-MIRCEA, SPYROPOULOS, ALEX C., FALANGA, ANNA, MARAVEYAS, ANTHONY, LIEW, AARON, SCHULMAN, SAM, BELCH, JILL, GEROTZIAFAS, GRIGORIOS, MARSCHANG, PETER, COSMI, BENILDE, SPAAK, JONAS, SYRIGOS, KONSTANTINOS
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Anticoagulants/therapeutic use Cancer Cardiac and Cardiovascular Systems Clinical Medicine Clinical trials Coagulation Coronaviruses COVID-19 COVID-19/complications Endothelial Cells Epidemiology Health risks Heparin Heparin, Low-Molecular-Weight/therapeutic use Humans Kardiologi Klinisk medicin Life Sciences Low molecular weights Medical and Health Sciences Medicin och hälsovetenskap Molecular weight Neoplasms/complications Patients Prospective Studies Risk analysis Risk assessment Risk Factors RNA, Viral SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Subgroups Thromboembolism Thrombosis Thrombosis/drug therapy Venous Thromboembolism/drug therapy
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!